Anlotinib in Advanced Solid Tumors With FGFR Alteration

NCT03929965 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Changzheng Hospital